Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Current Partnering

Current Partnering Market Research Reports

Current Partnering: The source of best practice for dealmakers

Current Partnering is the leading publisher of partnering deal terms and best practice for dealmakers. Report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities. 



Genitourinary Deals and Alliances of 2014
The Genitourinary Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Genetic Disorders Deals and Alliances of 2014
The Genetic Disorders Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfron
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Multiple Sclerosis Partnering 2010-2015
The Multiple Sclerosis Partnering 2010-2015 report provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in multiple sclerosis partnering deals Top multiple sclerosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Multiple Sclerosis Partnering 2010-2015 provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of multiple sclerosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors multiple
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Gastrointestinal Deals and Alliances of 2014
The Gastrointestinal Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Inflammatory Bowel Disease Partnering 2010-2015
The Inflammatory Bowel Disease Partnering 2010-2015 report provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in inflammatory bowel disease partnering deals Top inflammatory bowel disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Inflammatory Bowel Disease Partnering 2010-2015 provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of inflammatory bowel disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a righ
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Central Nervous System Deals and Alliances of 2014
The Central Nervous System Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, u
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Cardiovascular Deals and Alliances of 2014
The Cardiovascular Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Crohns Disease Partnering 2010-2015
The Crohn’s disease Partnering 2010-2015 report provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Crohn’s disease partnering deals Top Crohn’s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Crohn’s Disease Partnering 2010-2015 provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of Crohn’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license t
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Hospital Care Deals and Alliances of 2014
The Hospital Care Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Motor Neurone Disease Partnering 2010-2015
The Motor Neurone Partnering 2010-2015 report provides understanding and access to the motor neurone partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in motor neurone partnering deals Top motor neurone deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Motor Neurone Partnering 2010-2015 provides understanding and access to the motor neurone partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of motor neurone partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors motor neurone technology. These deals tend
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Autoimmune Partnering Terms and Agreements
The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in autoimmune partnering deals Average deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract documents Top autoimmune deals by value Most active autoimmune dealmakers The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and w
Published Date: Mar 2015
Published By: Current Partnering

Price: $2995
Non-Hodgkin Lymphoma Partnering 2010-2015
The Non-Hodgkin Lymphoma Partnering 2010-2015 report provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in non-hodgkin lymphoma partnering deals Top non-hodgkin lymphoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Hodgkin Lymphoma Partnering 2010-2015 provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of non-hodgkin lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors non-
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Parkinsons Disease Partnering 2010-2015
The Parkinson’s Disease Partnering 2010-2015 report provides understanding and access to the parkinson’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in parkinson’s disease partnering deals Top parkinson’s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Parkinson’s disease Partnering 2010-2015 provides understanding and access to the parkinson’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of parkinson’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Neuropathy Partnering 2010-2015
The Neuropathy Partnering 2010-2015 report provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in neuropathy partnering deals Top neuropathy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Neuropathy Partnering 2010-2015 provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of neuropathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors neuropathy technology. These deals tend to be multicomponent, star
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Big pharma Deals and Alliances of 2014
The Big Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014. De
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Pharmaceutical Deals and Alliances of 2014
The Pharmaceutical Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Drug Delivery Deals and Alliances of 2014
The Drug Delivery Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Academic-Non-Profit Deals and Alliances of 2014
The Academic/Non-Profit Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfr
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Breast Cancer Partnering 2010-2015
The Breast Cancer Partnering 2010-2015 report provides understanding and access to the breast Cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in breast cancer partnering deals Top breast cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Breast Cancer Partnering 2010-2015 provides understanding and access to the breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of breast cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors breast cancer technology. These deals tend
Published Date: Mar 2015
Published By: Current Partnering

Price: $1795
Gastric Cancer Partnering 2010-2015
The Gastric Cancer Partnering 2010-2015 report provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastric cancer partnering deals Top gastric cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastric Cancer Partnering 2010-2015 provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of gastric cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors gastric cancer technology. These dea
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Biotechnology Deals and Alliances of 2014
The Biotechnology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Generic Pharma Deals and Alliances of 2014
The Generic Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Specialty Pharma Deals and Alliances of 2014
The Specialty Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Big Biotech Deals and Alliances of 2014
A review of big biotech partnering trends and comprehensive directory of deals and alliances announced during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014. Deals are listed by headline value, signed by bigbiotech, and most active bigbiotech. Where the deal has a
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Genomics Deals and Alliances of 2014
The Genomics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active de
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Companion Diagnostics Deals and Alliances of 2014
The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Merger and Acquisition Deals and Alliances of 2014
The Merger and Acquisition Deals of 2014 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s M&A dealmaking and business activities. Chapter 1 provides an overview of the trends in M&A dealmaking during 2014. Chapter 2 provides a review of the leading M&A deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most activ
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Biomarker Deals and Alliances of 2014
The Biomarker Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Topical Drug Delivery Partnering 2010-2015
Topical Drug Delivery Partnering 2010-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in topical drug delivery partnering deals Top topical drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Topical Drug Delivery Partnering 2010-2015 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter topical drug delivery partnering deals. The majority of deals are discovery or development stage whereby the license
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Vaccine Deals and Alliances of 2014
The Vaccine Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active d
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Transdermal Drug Delivery Partnering 2010-2015
Transdermal Drug Delivery Partnering 2010-2015 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in transdermal drug delivery partnering deals Top transdermal drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Transdermal Drug Delivery Partnering 2010-2015 provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter transdermal drug delivery partnering deals. The majority of deals are discovery or development
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Cell Therapy Deals and Alliances of 2014
The Cell Therapy Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most act
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Bladder Cancer Partnering 2010-2015
The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bladder cancer partnering deals Top bladder cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Bladder Cancer Partnering 2010-2015 provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of bladder cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors bladder cancer technology. These deals
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Brain Cancer Partnering 2010-2015
The Brain Cancer Partnering 2010-2015 report provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in brain cancer partnering deals Top brain cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Brain Cancer Partnering 2010-2015 provides understanding and access to the brain cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of brain cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors brain cancer technology. These deals tend to be mult
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Marketed Stage Deals and Alliances of 2014
The Marketed Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Colorectal Cancer Partnering 2010-2015
The Colorectal Cancer Partnering 2010-2015 report provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in colorectal cancer partnering deals Top colorectal cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Colorectal Cancer Partnering 2010-2015 provides understanding and access to the colorectal cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of colorectal cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors colorectal cancer
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Pre-Clinical Stage Deals and Alliances of 2014
The Pre-Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Gastrointestinal Symptoms Partnering 2010-2015
The Gastrointestinal Symptoms Partnering 2010-2015 report provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastrointestinal symptoms partnering deals Top gastrointestinal symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastrointestinal Symptoms Partnering 2010-2015 provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of gastrointestinal symptoms partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Head and Neck Cancer Partnering 2010-2015
The Head and Neck Cancer Partnering 2010-2015 report provides understanding and access to the head and neck cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in head and neck cancer partnering deals Top head and neck cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Head and Neck Cancer Partnering 2010-2015 provides understanding and access to the head and neck cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of head and neck cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licens
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Sexual Health Deals and Alliances of 2014
The Sexual Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Congestive Heart Failure Partnering 2010-2015
The Congestive Heart Failure Partnering 2010-2015 report provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in congestive heart failure partnering deals Top congestive heart failure deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Congestive Heart Failure Partnering 2010-2015 provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of congestive heart failure partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an opti
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Lymphoma Partnering 2010-2015
The Lymphoma Partnering 2010-2015 report provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in lymphoma partnering deals Top lymphoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Lymphoma Partnering 2010-2015 provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lymphoma technology. These deals tend to be multicomponent, starting with collab
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Sensory Organ Deals and Alliances of 2014
The Sensory Organ Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Melanoma Partnering 2010-2015
The Melanoma Partnering 2010-2015 report provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in melanoma partnering deals Top melanoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Melanoma Partnering 2010-2015 provides understanding and access to the melanoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of melanoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors melanoma technology. These deals tend to be multicomponent, starting with coll
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Multiple Myeloma Partnering 2010-2015
The Multiple Myeloma Partnering 2010-2015 report provides understanding and access to the multiple myeloma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in multiple myeloma partnering deals Top multiple myeloma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Multiple myeloma Partnering 2010-2015 provides understanding and access to the multiple myeloma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of multiple myeloma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors multiple myeloma technol
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Traumatic Brain Injury Partnering 2010-2015
The Traumatic Brain Injury Partnering 2010-2015 report provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in traumatic brain injury partnering deals Top traumatic brain injury deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Traumatic Brain Injury Partnering 2010-2015 provides understanding and access to the traumatic brain injury partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of traumatic brain injury partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to li
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Ovarian Cancer Partnering 2010-2015
The Ovarian Cancer Partnering 2010-2015 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ovarian cancer partnering deals Top ovarian cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Ovarian Cancer Partnering 2010-2015 provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of ovarian cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ovarian cancer technology. These deals
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Psychiatry Deals and Alliances of 2014
The Psychiatry Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Pediatrics Deals and Alliances of 2014
The Pediatrics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Stroke Partnering 2010-2015
The Stroke Partnering 2010-2015 report provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in stroke partnering deals Top stroke deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Stroke Partnering 2010-2015 provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of stroke partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors stroke technology. These deals tend to be multicomponent, starting with collaborative R&
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Prostate Cancer Partnering 2010-2015
The Prostate cancer Partnering 2010-2015 report provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in prostate cancer partnering deals Top prostate cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Prostate cancer Partnering 2010-2015 provides understanding and access to the prostate cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of prostate cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors prostate cancer technology. T
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Migraine Partnering 2010-2015
The Migraine Partnering 2010-2015 report provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in migraine partnering deals Top migraine deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Migraine Partnering 2010-2015 provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of migraine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors migraine technology. These deals tend to be multicomponent, starting with coll
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Solid Tumor Partnering 2010-2015
he Solid Tumor Cancer Partnering 2010-2015 report provides understanding and access to the solid tumor cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in solid tumor cancer partnering deals Top solid tumor cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Solid Tumor Cancer Partnering 2010-2015 provides understanding and access to the solid tumor cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of solid tumor cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors solid tumor
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Oncology Deals and Alliances of 2014
The Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, milest
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Acute and Chronic Myelogenous Leukemia Partnering 2010-2015
The Acute and Chronic Myelogenous Leukemia Partnering 2010-2015 report provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in acute and chronic myelogenous leukemia partnering deals Top acute and chronic myelogenous leukemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Acute and Chronic Myelogenous Leukemia Partnering 2010-2015 provides understanding and access to the acute and chronic myelogenous leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of acute and chronic myelogenous leukemia partnering deals. The majo
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Hypertension Partnering 2010-2015
The Hypertension Partnering 2010-2015 report provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypertension partnering deals Top hypertension deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hypertension Partnering 2010-2015 provides understanding and access to the hypertension partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypertension partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hypertension technology. These deals tend to be mu
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Coronary Artery Disease Partnering 2010-2015
The Coronary Artery Disease Partnering 2010-2015 report provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in coronary artery disease partnering deals Top coronary artery disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Coronary Artery Disease Partnering 2010-2015 provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of coronary artery disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Obstetrics Deals and Alliances of 2014
The Obstetrics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Epilepsy Partnering 2010-2015
The Epilepsy Partnering 2010-2015 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in epilepsy partnering deals Top epilepsy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Epilepsy Partnering 2010-2015 provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of epilepsy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors epilepsy technology. These deals tend to be multicomponent, starting with collab
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Atherosclerosis Partnering 2010-2015
The Atherosclerosis Partnering 2010-2015 report provides understanding and access to the atherosclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in atherosclerosis partnering deals Top atherosclerosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Atherosclerosis Partnering 2010-2015 provides understanding and access to the atherosclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of atherosclerosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors atherosclerosis technology. The
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Oral Health Partnering 2010-2015
The Oral Health Partnering 2010-2015 report provides understanding and access to the oral health partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in oral health partnering deals Top oral health deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Oral Health Partnering 2010-2015 provides understanding and access to the oral health partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of oral health partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors oral health technology. These deals tend to be multicompone
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Cosmetics Partnering 2010-2015
The Cosmetics Partnering 2010-2015 report provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cosmetics partnering deals Top cosmetics deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cosmetics Partnering 2010-2015 provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of cosmetics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cosmetics technology. These deals tend to be multicomponent, starting w
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Arrhythmia Partnering 2010-2015
The Arrhythmia Partnering 2010-2015 report provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in arrhythmia partnering deals Top arrhythmia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Arrhythmia Partnering 2010-2015 provides understanding and access to the arrhythmia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of arrhythmia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors arrhythmia technology. These deals tend to be multicomponent, star
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Pain Partnering 2010-2015
The Pain Partnering 2010-2015 report provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pain partnering deals Top pain deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pain Partnering 2010-2015 provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of pain partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pain technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercia
Published Date: Mar 2015
Published By: Current Partnering

Price: $1795
Acne Partnering 2010-2015
The Acne Partnering 2010-2015 report provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in acne partnering deals Top acne deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Acne Partnering 2010-2015 provides understanding and access to the acne partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of acne partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors acne technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercia
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Cervical Cancer Partnering 2010-2015
The Cervical Cancer Partnering 2010-2015 report provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cervical cancer partnering deals Top cervical cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cervical Cancer Partnering 2010-2015 provides understanding and access to the cervical cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of cervical cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cervical cancer technology. T
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Musculoskeletal Deals and Alliances of 2014
The Musculoskeletal Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Metabolic Deals and Alliances of 2014
The Metabolic Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, miles
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Dermatitis Partnering 2010-2015
The Dermatitis Partnering 2010-2015 report provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dermatitis partnering deals Top dermatitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dermatitis Partnering 2010-2015 provides understanding and access to the dermatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dermatitis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dermatitis technology. These deals tend to be multicomponent, st
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Immunology Deals and Alliances of 2014
The Immunology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Hematology Deals and Alliances of 2014
The Hematology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Psoriasis Partnering 2010-2015
The Psoriasis Partnering 2010-2015 report provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in psoriasis partnering deals Top psoriasis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Psoriasis Partnering 2010-2015 provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of psoriasis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psoriasis technology. These deals tend to be multicomponent, starting w
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Dermatology Deals and Alliances of 2014
The Dermatology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Dental Deals and Alliances of 2014
The Dental Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mileston
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Wound Healing Partnering 2010-2015
The Wound Healing Partnering 2010-2015 report provides understanding and access to the wound healing partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in wound healing partnering deals Top wound healing deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Wound Healing Partnering 2010-2015 provides understanding and access to the wound healing partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of wound healing partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors wound healing technology. These deals tend
Published Date: Mar 2015
Published By: Current Partnering

Price: $1795
Leukemia Partnering 2010-2015
The Leukemia Partnering 2010-2015 report provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in leukemia partnering deals Top leukemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Leukemia Partnering 2010-2015 provides understanding and access to the leukemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of leukemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors leukemia technology. These deals tend to be multicomponent, starting with coll
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Liver Cancer Partnering 2010-2015
The Liver Cancer Partnering 2010-2015 report provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in liver cancer partnering deals Top Liver cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Liver Cancer Partnering 2010-2015 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Liver cancer technology. These deals tend to be mu
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Lung Cancer Partnering 2010-2015
The Lung Cancer Partnering 2010-2015 report provides understanding and access to the lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in lung cancer partnering deals Top lung cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Lung Cancer Partnering 2010-2015 provides understanding and access to the lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to be multicompo
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Pancreatic Cancer Partnering 2010-2015
The Pancreatic cancer Partnering 2010-2015 report provides understanding and access to the pancreatic cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pancreatic cancer partnering deals Top pancreatic cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pancreatic cancer Partnering 2010-2015 provides understanding and access to the pancreatic cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of pancreatic cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pancreatic canc
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the clinical stage partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achi
Published Date: Mar 2015
Published By: Current Partnering

Price: $2995
Cancer Symptoms Partnering 2010-2015
The Cancer Symptoms Partnering 2010-2015 report provides understanding and access to the Cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer symptoms partnering deals Top cancer symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cancer Symptoms Partnering 2010-2015 provides understanding and access to the Cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest cancer symptoms agreements announced in the healthcare sectors, covering: Symptoms Oral mucositis Cancer pain Bone Neuropathic Muscular Lymphoedema Alopecia Cachexia Ulcers Dys
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Non-Small Cell Lung Cancer Partnering 2010-2015
The Non-Small Cell Lung Cancer Partnering 2010-2015 report provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in non-small cell lung cancer partnering deals Top non-small cell lung cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Small Cell Lung Cancer Partnering 2010-2015 provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of non-small cell lung cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a ri
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Discovery Stage Partnering Terms and Agreements
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the discovery stage partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to a
Published Date: Mar 2015
Published By: Current Partnering

Price: $3495
Myocardial Infarction Partnering 2010-2015
The Myocardial Infarction Partnering 2010-2015 report provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in myocardial infarction partnering deals Top myocardial infarction deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Myocardial Infarction Partnering 2010-2015 provides understanding and access to the myocardial infarction partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of myocardial infarction partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license t
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest preclinical agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner’s neg
Published Date: Mar 2015
Published By: Current Partnering

Price: $2995
Hypercholesterolemia Partnering 2010-2015
The Hypercholesterolemia Partnering 2010-2015 report provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hypercholesterolemia partnering deals Top hypercholesterolemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hypercholesterolemia Partnering 2010-2015 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypercholesterolemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the lice
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Injectable Drug Delivery Partnering 2010-2015
Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in injectable drug delivery partnering deals Top injectable drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Injectable Drug Delivery Partnering 2010-2015 provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter injectable drug delivery partnering deals. The majority of deals are discovery or development stage whereb
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Targeted Drug Delivery Partnering 2010-2015
Targeted Drug Delivery Partnering 2010-2015 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. Trends in targeted drug delivery partnering deals Top targeted drug delivery deals by value Deals listed by company A-Z, deal type, stage of development, therapy type Targeted Drug Delivery Partnering 2010-2015 provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter targeted drug delivery partnering deals. The majority of deals are discovery or development stage whereby th
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Antibody Deals and Alliances of 2014
The Antibody Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of leading deals by deal values, most active
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Clinical Stage Deals and Alliances of 2014
The Clinical Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014.
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Discovery Stage Deals and Alliances of 2014
The Discovery Stage Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Respiratory Deals and Alliances of 2014
The Respiratory Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Public Health Deals and Alliances of 2014
The Public Health Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Diagnostics Deals and Alliances of 2014
The Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, miles
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Ophthalmics Deals and Alliances of 2014
The Ophthalmics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mil
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Infectives Deals and Alliances of 2014
The Infectives Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Gynecology Deals and Alliances of 2014
The Gynecology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, mile
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Infectious Vaccines Partnering Terms and Agreements
The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.  The report also includes adjuvant deals and alliances.   This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expec
Published Date: Jan 2015
Published By: Current Partnering

Price: $1995
Antibiotics Partnering Terms and Agreements
The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in antibiotics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Antibiotics partnering contract documents Top antibiotics deals by value   The Antibiotics Partnering Terms and Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter antibiotics partnering deals. The majority of deals are early development stage whereby
Published Date: Jan 2015
Published By: Current Partnering

Price: $1995
Antibody Partnering Terms and Agreements
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.   This report provides details of the latest antibody agreements announced in the healthcare sectors, covering:   Antibodies Antibody-drug conjugates Monoclonal a
Published Date: Jan 2015
Published By: Current Partnering

Price: $2995